Modeling and optimization of parallelized immunomagnetic nanopore sorting for surface marker specific isolation of extracellular vesicles from complex media.
Autorzy:
Lin AA; Department of Bioengineering, University of Pennsylvania, 210 S. 33rd St., Philadelphia, PA, 19104, USA.; Perelman School of Medicine, University of Pennsylvania, 3400 Civic Center Blvd., Philadelphia, PA, 19104, USA. Shen H; Department of Bioengineering, University of Pennsylvania, 210 S. 33rd St., Philadelphia, PA, 19104, USA. Spychalski G; Department of Bioengineering, University of Pennsylvania, 210 S. 33rd St., Philadelphia, PA, 19104, USA.; Perelman School of Medicine, University of Pennsylvania, 3400 Civic Center Blvd., Philadelphia, PA, 19104, USA. CarpenterEL; Perelman School of Medicine, University of Pennsylvania, 3400 Civic Center Blvd., Philadelphia, PA, 19104, USA. Issadore D; Department of Bioengineering, University of Pennsylvania, 210 S. 33rd St., Philadelphia, PA, 19104, USA. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Aug 16; Vol. 13 (1), pp. 13292. Date of Electronic Publication: 2023 Aug 16.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
Transcriptional profiling of single tumour cells from pleural effusions reveals heterogeneity of epithelial to mesenchymal transition and extra-cellular matrix marker expression.
Autorzy:
Sen M; Department of Medicine, Division of Hematology and Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Hausler RM; Department of Medicine, Division of Hematology and Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Dulmage K; Life Science Innovation, BD Technologies and Innovations, Durham, North Carolina, USA. Black TA; Department of Medicine, Division of Hematology and Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Murphy W; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Pletcher CH Jr; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Wang L; Life Science Innovation, BD Technologies and Innovations, Durham, North Carolina, USA. Chen C; Life Science Innovation, BD Technologies and Innovations, Durham, North Carolina, USA. Yee SS; Department of Medicine, Division of Hematology and Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Bornheimer SJ; BD Biosciences, San Jose, California, USA. Maxwell KN; Department of Medicine, Division of Hematology and Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Stanger BZ; Department of Medicine, Division of Gastroenterology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Moore JS; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Thompson JC; Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, Thoracic Oncology Group, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA. CarpenterEL; Department of Medicine, Division of Hematology and Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Development of a robust radiomic biomarker of progression-free survival in advanced non-small cell lung cancer patients treated with first-line immunotherapy.
Autorzy:
Singh A; Department of Radiology, Center for Biomedical Image Computing and Analytics (CBICA), University of Pennsylvania, Rm D702 Richards Bldg., 3700 Hamilton Walk, Philadelphia, PA, 19104, USA.; Department of Bioengineering, University of Pennsylvania, Philadelphia, PA, 19104, USA. Horng H; Department of Bioengineering, University of Pennsylvania, Philadelphia, PA, 19104, USA. Roshkovan L; Department of Radiology, Center for Biomedical Image Computing and Analytics (CBICA), University of Pennsylvania, Rm D702 Richards Bldg., 3700 Hamilton Walk, Philadelphia, PA, 19104, USA. Weeks JK; Department of Radiology, Center for Biomedical Image Computing and Analytics (CBICA), University of Pennsylvania, Rm D702 Richards Bldg., 3700 Hamilton Walk, Philadelphia, PA, 19104, USA. Hershman M; Department of Radiology, Center for Biomedical Image Computing and Analytics (CBICA), University of Pennsylvania, Rm D702 Richards Bldg., 3700 Hamilton Walk, Philadelphia, PA, 19104, USA. Noël P; Department of Radiology, Center for Biomedical Image Computing and Analytics (CBICA), University of Pennsylvania, Rm D702 Richards Bldg., 3700 Hamilton Walk, Philadelphia, PA, 19104, USA. Luna JM; Department of Radiology, Center for Biomedical Image Computing and Analytics (CBICA), University of Pennsylvania, Rm D702 Richards Bldg., 3700 Hamilton Walk, Philadelphia, PA, 19104, USA. Cohen EA; Department of Radiology, Center for Biomedical Image Computing and Analytics (CBICA), University of Pennsylvania, Rm D702 Richards Bldg., 3700 Hamilton Walk, Philadelphia, PA, 19104, USA. Pantalone L; Department of Radiology, Center for Biomedical Image Computing and Analytics (CBICA), University of Pennsylvania, Rm D702 Richards Bldg., 3700 Hamilton Walk, Philadelphia, PA, 19104, USA. Shinohara RT; Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, PA, 19104, USA. Bauml JM; Department of Medicine, Division of Hematology-Oncology, University of Pennsylvania, Philadelphia, PA, 19104, USA. Thompson JC; Department of Medicine, Division of Hematology-Oncology, University of Pennsylvania, Philadelphia, PA, 19104, USA.; Department of Medicine, Pulmonary, Allergy and Critical Care Medicine, Thoracic Oncology Group, University of Pennsylvania, Philadelphia, PA, 19104, USA. Aggarwal C; Department of Medicine, Division of Hematology-Oncology, University of Pennsylvania, Philadelphia, PA, 19104, USA. CarpenterEL; Department of Medicine, Division of Hematology-Oncology, University of Pennsylvania, Philadelphia, PA, 19104, USA. Katz SI; Department of Radiology, Center for Biomedical Image Computing and Analytics (CBICA), University of Pennsylvania, Rm D702 Richards Bldg., 3700 Hamilton Walk, Philadelphia, PA, 19104, USA. Kontos D; Department of Radiology, Center for Biomedical Image Computing and Analytics (CBICA), University of Pennsylvania, Rm D702 Richards Bldg., 3700 Hamilton Walk, Philadelphia, PA, 19104, USA. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 Jun 15; Vol. 12 (1), pp. 9993. Date of Electronic Publication: 2022 Jun 15.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
NRF2 and Key Transcriptional Targets in Melanoma Redox Manipulation.
Autorzy:
CarpenterEL; Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Corvallis, OR 97331, USA. Becker AL; Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Corvallis, OR 97331, USA.; John A. Burns School of Medicine, University of Hawaii, Honolulu, HI 96813, USA. Indra AK; Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Corvallis, OR 97331, USA.; Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA.; Department of Biochemistry and Biophysics, Oregon State University, Corvallis, OR 97331, USA.; Linus Pauling Science Center, Oregon State University, Corvallis, OR 97331, USA.; Department of Dermatology, Oregon Health & Science University, Portland, OR 97239, USA.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2022 Mar 16; Vol. 14 (6). Date of Electronic Publication: 2022 Mar 16.
Impact of Interobserver Variability in Manual Segmentation of Non-Small Cell Lung Cancer (NSCLC) Applying Low-Rank Radiomic Representation on Computed Tomography.
Autorzy:
Hershman M; Department of Radiology, University of Pennsylvania, Philadelphia, PA 19104, USA. Yousefi B; Department of Radiology, University of Pennsylvania, Philadelphia, PA 19104, USA.; Center for Biomedical Image Computing and Analytics, University of Pennsylvania, Philadelphia, PA 19104, USA. Serletti L; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. Galperin-Aizenberg M; Department of Radiology, University of Pennsylvania, Philadelphia, PA 19104, USA. Roshkovan L; Department of Radiology, University of Pennsylvania, Philadelphia, PA 19104, USA. Luna JM; Department of Radiology, University of Pennsylvania, Philadelphia, PA 19104, USA.; Center for Biomedical Image Computing and Analytics, University of Pennsylvania, Philadelphia, PA 19104, USA. Thompson JC; Section of Interventional Pulmonology, Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. Aggarwal C; Division of Hematology and Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. CarpenterEL; Division of Hematology and Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. Kontos D; Department of Radiology, University of Pennsylvania, Philadelphia, PA 19104, USA.; Center for Biomedical Image Computing and Analytics, University of Pennsylvania, Philadelphia, PA 19104, USA. Katz SI; Department of Radiology, University of Pennsylvania, Philadelphia, PA 19104, USA.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2021 Nov 28; Vol. 13 (23). Date of Electronic Publication: 2021 Nov 28.
Combining radiomic phenotypes of non-small cell lung cancer with liquid biopsy data may improve prediction of response to EGFR inhibitors.
Autorzy:
Yousefi B; Department of Radiology, University of Pennsylvania, Philadelphia, PA, 19104, USA. LaRiviere MJ; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, 19104, USA. Cohen EA; Department of Radiology, University of Pennsylvania, Philadelphia, PA, 19104, USA. Buckingham TH; Division of Hematology and Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA. Yee SS; Division of Hematology and Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA. Black TA; Division of Hematology and Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA. Chien AL; Division of Hematology and Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA. Noël P; Department of Radiology, University of Pennsylvania, Philadelphia, PA, 19104, USA. Hwang WT; Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, PA, 19104, USA. Katz SI; Department of Radiology, University of Pennsylvania, Philadelphia, PA, 19104, USA. Aggarwal C; Division of Hematology and Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA. Thompson JC; Section of Interventional Pulmonology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA. CarpenterEL; Division of Hematology and Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA. Kontos D; Department of Radiology, University of Pennsylvania, Philadelphia, PA, 19104, USA. .; Computational Biomarker Imaging Group (CBIG), Department of Radiology, University of Pennsylvania, Rm D702 Richards Bldg., 3700 Hamilton Walk, Philadelphia, PA, 19104, USA. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 May 11; Vol. 11 (1), pp. 9984. Date of Electronic Publication: 2021 May 11.
Typ publikacji:
Journal Article; Observational Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Using an interprofessional team to provide refugee healthcare in an academic medical centre.
Autorzy:
Elmore CE; Department of Family Medicine, University of Virginia Health System, Charlottesville, Virginia, USA. Tingen JM; Department of Family Medicine, University of Virginia Health System, Charlottesville, Virginia, USA.; Department of Pharmacy Services, University of Virginia Health System, Charlottesville, Virginia, USA. Fredgren K; Department of Social Work, University of Virginia Health System, Charlottesville, Virginia, USA. Dalrymple SN; Department of Family Medicine, University of Virginia Health System, Charlottesville, Virginia, USA. Compton RM; Department of Family Medicine, University of Virginia Health System, Charlottesville, Virginia, USA. CarpenterEL; Department of Family Medicine, University of Virginia Health System, Charlottesville, Virginia, USA. Allen CW; Department of Family Medicine, University of Virginia Health System, Charlottesville, Virginia, USA. Hauck FR; Department of Family Medicine, University of Virginia Health System, Charlottesville, Virginia, USA.; Department of Public Health Sciences, University of Virginia Health System, Charlottesville, Virginia, USA.
Pokaż więcej
Źródło:
Family medicine and community health [Fam Med Community Health] 2019 Jul 11; Vol. 7 (3), pp. e000091. Date of Electronic Publication: 2019 Jul 11 (Print Publication: 2019).
An integrated flow cytometry-based platform for isolation and molecular characterization of circulating tumor single cells and clusters.
Autorzy:
Bhagwat N; Division of Gastroenterology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. Dulmage K; BD Technologies and Innovation, Research Triangle Park, NC, USA. Pletcher CH Jr; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. Wang L; BD Technologies and Innovation, Research Triangle Park, NC, USA. DeMuth W; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. Sen M; Division of Hematology and Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. Balli D; Division of Gastroenterology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. Yee SS; Division of Hematology and Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. Sa S; BD Biosciences, San Jose, CA, USA. Tong F; BD Technologies and Innovation, Research Triangle Park, NC, USA. Yu L; BD Biosciences, San Jose, CA, USA. Moore JS; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. Stanger BZ; Division of Gastroenterology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. Dixon EP; BD Technologies and Innovation, Research Triangle Park, NC, USA. CarpenterEL; Division of Hematology and Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2018 Mar 22; Vol. 8 (1), pp. 5035. Date of Electronic Publication: 2018 Mar 22.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Validation Study
Feasibility of monitoring advanced melanoma patients using cell-free DNA from plasma.
Autorzy:
Gangadhar TC; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.; Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. Savitch SL; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. Yee SS; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. Xu W; Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. Huang AC; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.; Institue for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.; Parker Institute of Immunotherapy, University of Pennsylvania, Philadelphia, PA, USA. Harmon S; Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. Lieberman DB; Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA. Soucier D; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. Fan R; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. Black TA; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. Morrissette JJD; Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA. Salathia N; Illumina Inc., San Diego, CA, USA. Waters J; Illumina Inc., San Diego, CA, USA. Zhang S; Illumina Inc., San Diego, CA, USA. Toung J; Grail Bio, Redwood City, CA, USA. van Hummelen P; Illumina Inc., San Diego, CA, USA. Fan JB; Illumina Inc., San Diego, CA, USA. Xu X; Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA. Amaravadi RK; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.; Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. Schuchter LM; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.; Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. Karakousis GC; Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA, USA. Hwang WT; Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.; Department of Biostatistics & Epidemiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. CarpenterEL; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.; Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Pokaż więcej
Źródło:
Pigment cell & melanoma research [Pigment Cell Melanoma Res] 2018 Jan; Vol. 31 (1), pp. 73-81. Date of Electronic Publication: 2017 Oct 23.
Typ publikacji:
Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Ablation of epidermal RXRα in cooperation with activated CDK4 and oncogenic NRAS generates spontaneous and acute neonatal UVB induced malignant metastatic melanomas.
Autorzy:
Chagani S; Molecular and Cellular Biology Program, OSU, Corvallis, 97331, OR, USA.; Department of Pharmaceutical Sciences, College of Pharmacy, OSU, Corvallis, 97331, OR, USA. Wang R; Department of Pharmaceutical Sciences, College of Pharmacy, OSU, Corvallis, 97331, OR, USA.; Linus Pauling Institute, OSU, Corvallis, OR, USA. CarpenterEL; Department of Pharmaceutical Sciences, College of Pharmacy, OSU, Corvallis, 97331, OR, USA. Löhr CV; College of Veterinary Medicine, Oregon State University, Corvallis, Oregon, 97331, USA. Ganguli-Indra G; Molecular and Cellular Biology Program, OSU, Corvallis, 97331, OR, USA.; Department of Pharmaceutical Sciences, College of Pharmacy, OSU, Corvallis, 97331, OR, USA.; Knight Cancer Institute, Oregon Health & Science University (OHSU), Portland, 97239, OR, USA. Indra AK; Molecular and Cellular Biology Program, OSU, Corvallis, 97331, OR, USA. .; Department of Pharmaceutical Sciences, College of Pharmacy, OSU, Corvallis, 97331, OR, USA. .; Linus Pauling Institute, OSU, Corvallis, OR, USA. .; Knight Cancer Institute, Oregon Health & Science University (OHSU), Portland, 97239, OR, USA. .; Department of Dermatology, OHSU, Portland, 97239, OR, USA. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2017 Nov 09; Vol. 17 (1), pp. 736. Date of Electronic Publication: 2017 Nov 09.
A novel approach for next-generation sequencing of circulating tumor cells.
Autorzy:
Yee SS; Department of Medicine University of Pennsylvania Perelman School of Medicine Philadelphia Pennsylvania. Lieberman DB; Department of Pathology and Laboratory Medicine Hospital of the University of Pennsylvania Philadelphia Pennsylvania. Blanchard T; Department of Cancer BiologyUniversity of Pennsylvania Perelman School of MedicinePhiladelphiaPennsylvania; Abramson Family Cancer Research InstituteUniversity of Pennsylvania Perelman School of MedicinePhiladelphiaPennsylvania. Rader J; Division of Oncology Center for Childhood Cancer Research Children's Hospital of Philadelphia Philadelphia Pennsylvania. Zhao J; Department of Pathology and Laboratory Medicine Hospital of the University of Pennsylvania Philadelphia Pennsylvania. Troxel AB; Center for Clinical Epidemiology and BiostatisticsUniversity of PennsylvaniaPhiladelphiaPennsylvania; Abramson Cancer CenterUniversity of Pennsylvania Perelman School of MedicinePhiladelphiaPennsylvania. DeSloover D; Department of Pathology and Laboratory Medicine Hospital of the University of Pennsylvania Philadelphia Pennsylvania. Fox AJ; Department of Pathology and Laboratory Medicine Hospital of the University of Pennsylvania Philadelphia Pennsylvania. Daber RD; Department of Pathology and Laboratory Medicine Hospital of the University of Pennsylvania Philadelphia Pennsylvania. Kakrecha B; Department of Medicine University of Pennsylvania Perelman School of Medicine Philadelphia Pennsylvania. Sukhadia S; Department of Pathology and Laboratory Medicine Hospital of the University of Pennsylvania Philadelphia Pennsylvania. Belka GK; Department of Cancer BiologyUniversity of Pennsylvania Perelman School of MedicinePhiladelphiaPennsylvania; Abramson Family Cancer Research InstituteUniversity of Pennsylvania Perelman School of MedicinePhiladelphiaPennsylvania. DeMichele AM; Department of MedicineUniversity of Pennsylvania Perelman School of MedicinePhiladelphiaPennsylvania; Abramson Cancer CenterUniversity of Pennsylvania Perelman School of MedicinePhiladelphiaPennsylvania. Chodosh LA; Department of MedicineUniversity of Pennsylvania Perelman School of MedicinePhiladelphiaPennsylvania; Department of Cancer BiologyUniversity of Pennsylvania Perelman School of MedicinePhiladelphiaPennsylvania; Abramson Family Cancer Research InstituteUniversity of Pennsylvania Perelman School of MedicinePhiladelphiaPennsylvania. Morrissette JJ; Department of Pathology and Laboratory Medicine Hospital of the University of Pennsylvania Philadelphia Pennsylvania. CarpenterEL; Department of MedicineUniversity of Pennsylvania Perelman School of MedicinePhiladelphiaPennsylvania; Abramson Cancer CenterUniversity of Pennsylvania Perelman School of MedicinePhiladelphiaPennsylvania.
Pokaż więcej
Źródło:
Molecular genetics & genomic medicine [Mol Genet Genomic Med] 2016 Feb 28; Vol. 4 (4), pp. 395-406. Date of Electronic Publication: 2016 Feb 28 (Print Publication: 2016).
Activation of human B cells by the agonist CD40 antibody CP-870,893 and augmentation with simultaneous toll-like receptor 9 stimulation.
Autorzy:
CarpenterEL; Abramson Family Cancer Research Institute, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA. />Mick R Rüter J Vonderheide RH
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
